FBN1 Splice-Altering Mutations in Marfan Syndrome: A Case Report and Literature Review
Related Experiment Video
Updated: Aug 23, 2025

Biological Preparation and Mechanical Technique for Determining Viscoelastic Properties of Zonular Fibers
Published on: December 16, 2021
James Jiqi Wang1,2, Bo Yu1,2, Yang Sun1,2
1Division of Cardiology, Departments of Internal Medicine and Genetic Diagnosis Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Abstract:
Marfan syndrome (MFS) is a life-threatening autosomal dominant genetic disorder of connective tissue caused by the pathogenic mutation of FBN1. Whole exome sequencing and Sanger sequencing were performed to identify the pathogenic mutation. The transcriptional consequence of the splice-altering mutation was analyzed via minigene assays and reverse-transcription PCR. We identified a novel pathogenic mutation (c.8051+1G>C) in the splice site of exon 64 of the FBN1 gene in an MFS-pedigree. This mutation was confirmed to cause two different truncated transcripts (entire exon 64 skipping; partial exon 64 exclusion). We also systematically summarized previously reported transcriptional studies of pathogenic splice-altering mutations in the FBN1 gene to investigate the clinical and transcriptional consequences. In conclusion, we reported for the first time that a splice-altering mutation in the FBN1 gene leads to two abnormal transcripts simultaneously.
Insights
A novel FBN1 gene mutation causes Marfan syndrome by creating two abnormal transcripts. This study details the genetic and transcriptional consequences of this splice-altering mutation.
Area of Science:
- Genetics
- Molecular Biology
- Medical Science
Background:
- Marfan syndrome (MFS) is a severe genetic connective tissue disorder.
- It is caused by mutations in the FBN1 gene, affecting fibrillin-1 production.
- Understanding mutation consequences is crucial for MFS diagnosis and treatment.
Approach:
- Whole exome and Sanger sequencing identified a novel FBN1 splice-site mutation (c.8051+1G>C).
- Minigene assays and RT-PCR analyzed the transcriptional impact of the mutation.
- Previous FBN1 transcriptional studies were systematically reviewed.
Key Points:
- A novel pathogenic splice-altering mutation in FBN1 (c.8051+1G>C) was identified in an MFS family.
- This mutation leads to two distinct aberrant transcripts: complete exon 64 skipping and partial exon 64 exclusion.
- This is the first report of a single FBN1 splice-altering mutation causing two abnormal transcripts concurrently.
Conclusions:
- The identified FBN1 mutation is pathogenic and causes Marfan syndrome.
- The mutation results in complex alternative splicing, producing truncated fibrillin-1.
- This finding deepens the understanding of genotype-phenotype correlations in Marfan syndrome.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Aneurysm I: Introduction
Clot Retraction and Fibrinolysis

